Pharmabiz

IPA Karnataka State Branch bags ‘Special Achievement Award’ for the year 2025

IPA Karnataka State Branch bags ‘Special Achievement Award’ for the year 2025: Our Bureau, Bengaluru Thursday, November 27, ...
Pharmabiz

Samsung launches R20 ultrasound system redefining general imaging with next-gen AI

Samsung launches R20 ultrasound system redefining general imaging with next-gen AI: Our Bureau, Mumbai Thursday, November 27, ...
Pharmabiz

Danone in India announces nationwide initiative ‘IRON UP!’ to combat IDA

Danone in India announces nationwide initiative ‘IRON UP!’ to combat IDA: Our Bureau, Mumbai Thursday, November 27, 2025, ...
Pharmabiz

Fortis Gurugram hosts ‘HemeNext 1.0’ to showcase genomics, AI, cell therapy & robotics for the future of haematology

Fortis Gurugram hosts ‘HemeNext 1.0’ to showcase genomics, AI, cell therapy & robotics for the future of haematology: Our Bureau, Bengaluru Thursday, November 27, 2025, 17:30 ...
Pharmabiz

Dnyaan Prasad Global University faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing

Dnyaan Prasad Global University faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing: Our Bureau, Bengaluru Thursday, November 27, ...
Pharmabiz

Yuvrit Ayurveda raises $800K seed round from Incubate Fund Asia to build a modern ayurvedic clinic chain

Yuvrit Ayurveda raises $800K seed round from Incubate Fund Asia to build a modern ayurvedic clinic chain: Our Bureau, Bengaluru Thursday, November 27, 2025, 16:10 Hrs [IST] Yuvrit ...
Pharmabiz

Manipal Hospitals strengthens access to quality care for Maldivian patients under the Aasandha Scheme

Manipal Hospitals strengthens access to quality care for Maldivian patients under the Aasandha Scheme: Our Bureau, Bengaluru Thursday, November 27, 2025, 17:20 Hrs [IST] Manipal H ...
Pharmabiz

WHO approves OS Therapies’ daznelimgene lisbac for non-proprietary name for product candidate OST-HER2

WHO approves OS Therapies’ daznelimgene lisbac for non-proprietary name for product candidate OST-HER2: New York Thursday, November 27, 2025, 18:00 Hrs [IST] OS Therapies Inc, t ...
Pharmabiz

Novo Nordisk announces phase 2 clinical trial results of amycretin in people with type 2 diabetes

Novo Nordisk announces phase 2 clinical trial results of amycretin in people with type 2 diabetes: Bagsværd, Denmark Thursday, November 27, 2025, 13:00 Hrs [IST] Novo Nordisk, a ...
Pharmabiz

Chugai Pharma announces results from phase I/II study in Japan to evaluate the efficacy and safety of Port Delivery System with Ranibizumab in patients with nAMD & DME

Chugai Pharma announces results from phase I/II study in Japan to evaluate the efficacy and safety of Port Delivery System with Ranibizumab in patients with nAMD & DME ...
Pharmabiz

Teva Pharma receives European marketing approvals for Ponlimsi, biosimilar to Prolia and Degevma, biosimilar to Xgeva

Teva Pharma receives European marketing approvals for Ponlimsi, biosimilar to Prolia and Degevma, biosimilar to Xgeva: Tel Aviv, Israel Thursday, November 27, 2025, 11:00 Hrs [IST ...
Pharmabiz

Emversity with Cambridge University to strengthen the global employability of India’s healthcare workforce

Emversity with Cambridge University to strengthen the global employability of India’s healthcare workforce: Our Bureau, Bengaluru Thursday, November 27, 2025, 16:20 Hrs [IST] Em ...